HW&C
HC Wainwright & Co. Latest Price Targets & Analyst Ratings
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Communication Services
Consumer Discretionary
Consumer Staples
Energy
Financials
Healthcare
Industrials
Materials
Real Estate
Technology
Utilities
Communication Services
Advertising Agencies
Broadcasting
Electronic Gaming & Multimedia
Entertainment
Internet Content & Information
Publishing
Telecom Services
Consumer Discretionary
Apparel Manufacturing
Apparel Retail
Auto Manufacturers
Auto Parts
Auto & Truck Dealerships
Department Stores
Footwear & Accessories
Furnishings, Fixtures & Appliances
Gambling
Home Improvement Retail
Internet Retail
Leisure
Lodging
Luxury Goods
Packaging & Containers
Personal Services
Recreational Vehicles
Residential Construction
Resorts & Casinos
Restaurants
Specialty Retail
Textile Manufacturing
Travel Services
Consumer Staples
Beverages - Brewers
Beverages - Non-Alcoholic
Beverages - Wineries & Distilleries
Confectioners
Discount Stores
Education & Training Services
Farm Products
Food Distribution
Grocery Stores
Household & Personal Products
Packaged Foods
Tobacco
Energy
Oil & Gas Drilling
Oil & Gas Equipment & Services
Oil & Gas Exploration & Production
Oil & Gas Integrated
Oil & Gas Midstream
Oil & Gas Refining & Marketing
Thermal Coal
Uranium
Financials
Asset Management
Banks - Diversified
Banks - Regional
Capital Markets
Credit Services
Diversified Insurance
Financial Conglomerates
Financial Data & Stock Exchanges
Insurance Brokers
Life Insurance
Mortgage Finance
Property & Casualty Insurance
Reinsurance
Shell Companies
Specialty - Insurance
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Healthcare Plans
Health Information Services
Medical Care Facilities
Medical Devices
Medical Distribution
Medical Instruments & Supplies
Pharmaceutical Retailers
Industrials
Aerospace & Defense
Airlines
Airports & Air Services
Building Products & Equipment
Business Equipment & Supplies
Conglomerates
Consulting Services
Electrical Equipment & Parts
Engineering & Construction
Farm & Heavy Construction Machinery
Industrial Distribution
Infrastructure Operations
Integrated Freight & Logistics
Marine Shipping
Metal Fabrication
Pollution & Treatment Controls
Railroads
Rental & Leasing Services
Security & Protection Services
Specialty Business Services
Specialty Industrial Machinery
Staffing & Employment Services
Tools & Accessories
Trucking
Waste Management
Materials
Agricultural Inputs
Aluminum
Building Materials
Chemicals
Coking Coal
Copper
Gold
Lumber & Wood Production
Other Industrial Metals & Mining
Other Precious Metals & Mining
Paper & Paper Products
Silver
Specialty Chemicals
Steel
Real Estate
Diversified REIT
Healthcare Facilities REIT
Hotel & Motel REIT
Industrial REIT
Mortgage REIT
Office REIT
Real Estate Development
Real Estate Diversified
Real Estate Services
Residential REIT
Retail REIT
Specialty REIT
Technology
Communication Equipment
Computer Hardware
Consumer Electronics
Electronic Components
Electronics & Computer Distribution
Information Technology Services
Scientific & Technical Instruments
Semiconductor Equipment & Materials
Semiconductors
Software - Application
Software - Infrastructure
Solar
Utilities
Diversified Utilities
Electric Utilities
Gas Utilities
Independent Power Producers
Renewable Electricity
Water Utilities
Positive
Neutral
Negative
7 Days
1 Month
3 Months
6 Months
# | Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|---|
826 |
OKUR
826
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$35.6M
|
EZ
Edwin Zhang
| $2.57 | $280 |
10,795%
upside
| Buy |
21 Dec ‘21
3 years ago |
|
827 |
827
Sonnet BioTherapeutics
SONN
$22.5M
|
MK
Michael King
| $3.12 | $4,928 |
157,849%
upside
| Buy |
16 Dec ‘21
3 years ago |
|
828 |
828
Enliven Therapeutics
ELVN
$1.19B
|
EZ
Edwin Zhang
| $19.72 | $40 |
103%
upside
| Buy |
30 Nov ‘21
3 years ago |
|
829 |
829
InMed Pharmaceuticals
INM
$4.3M
|
RS
Raghuram Selvaraju
| $2.25 | $3,000 |
133,233%
upside
| Buy |
29 Nov ‘21
3 years ago |
|
830 |
NCNA
830
NuCana
NCNA
$5.51M
|
RB
Robert Burns
| $2.92 | $45,000 |
1,540,996%
upside
| Buy |
24 Nov ‘21
3 years ago |
|
831 |
IRD
831
Opus Genetics, Inc. Common Stock
IRD
$83.9M
|
AF
Andrew Fein
| $1.36 | $26 |
1,812%
upside
| Buy |
24 Nov ‘21
3 years ago |
|
832 |
832
GRI Bio
GRI
$3.92M
|
RS
Raghuram Selvaraju
| $1.57 | $360 |
22,830%
upside
| Buy |
22 Nov ‘21
3 years ago |
|
833 |
833
Cogent Biosciences
COGT
$1.77B
|
MK
Michael King
| $12.82 | $31 |
142%
upside
| Buy |
5 Nov ‘21
3 years ago |
|
834 |
834
Intellia Therapeutics
NTLA
$1.27B
|
MK
Michael King
| $11.88 | $182 |
1,432%
upside
| Buy |
5 Nov ‘21
3 years ago |
|
835 |
835
Regeneron Pharmaceuticals
REGN
$59.2B
|
MK
Michael King
| $556.53 | $844 |
52%
upside
| Buy |
5 Nov ‘21
3 years ago |
|
836 |
836
Catheter Precision
VTAK
$3.04M
|
VB
Vernon Bernardino
| $2.44 | $600 |
24,490%
upside
| Buy |
21 Oct ‘21
3 years ago |
|
837 |
837
Synlogic
SYBX
$17.2M
|
RS
Raghuram Selvaraju
| $1.46 | $105 |
7,092%
upside
| Buy |
13 Oct ‘21
3 years ago |
|
838 |
838
Ultragenyx Pharmaceutical
RARE
$3.04B
|
EZ
Edwin Zhang
| $31.50 | $106 |
237%
upside
| Buy |
30 Sep ‘21
4 years ago |
|
839 |
RDHL
839
Redhill Biopharma
RDHL
$3.31M
|
RS
Raghuram Selvaraju
| $1.42 | $21,000 |
1,478,773%
upside
| Buy |
15 Sep ‘21
4 years ago |
|
840 |
840
Diana Shipping
DSX
$207M
|
MF
Magnus Fyhr
| $1.97 | $9.50 |
382%
upside
| Buy |
13 Sep ‘21
4 years ago |
|
841 |
841
Genco Shipping & Trading
GNK
$776M
|
MF
Magnus Fyhr
| $17.96 | $30 |
67%
upside
| Buy |
13 Sep ‘21
4 years ago |
|
842 |
842
Star Bulk Carriers
SBLK
$2.22B
|
MF
Magnus Fyhr
| $19.72 | $35 |
77%
upside
| Buy |
13 Sep ‘21
4 years ago |
|
843 |
843
Safe Bulkers
SB
$456M
|
MF
Magnus Fyhr
| $4.52 | $6.50 |
44%
upside
| Buy |
13 Sep ‘21
4 years ago |
|
844 |
844
Immunic
IMUX
$81.6M
|
RS
Raghuram Selvaraju
| $0.8573 | $25 |
2,816%
upside
| Buy |
7 Sep ‘21
4 years ago |
|
845 |
845
Mersana Therapeutics
MRSN
$35.1M
|
EW
Edward White
| $7.66 | $700 |
9,038%
upside
| Buy |
30 Aug ‘21
4 years ago |
|
846 |
846
Lipocine
LPCN
$15.8M
|
OL
Oren Livnat
| $2.87 | $59.50 |
1,973%
upside
| Buy |
26 Aug ‘21
4 years ago |
|
847 |
847
Riot Platforms
RIOT
$4.97B
|
KD
Kevin Dede
| $15.21 | $50 |
229%
upside
| Buy |
24 Aug ‘21
4 years ago |
|
848 |
848
DHT Holdings
DHT
$2.03B
|
MF
Magnus Fyhr
| $12.17 | $8 |
34%
downside
| Buy |
11 Aug ‘21
4 years ago |
|
849 |
849
IDEAYA Biosciences
IDYA
$2.05B
|
EW
Edward White
| $24.74 | $30 |
21%
upside
| Buy |
11 Aug ‘21
4 years ago |
|
850 |
850
Corvus Pharmaceuticals
CRVS
$440M
|
SR
Swayampakula Ramakanth
| $6.17 | $6 |
3%
downside
| Buy |
16 Jul ‘21
4 years ago |
|